Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival.

MLA

Inomata, Takenori, et al. “Novel Immunotherapeutic Effects of Topically Administered Ripasudil (K-115) on Corneal Allograft Survival.” Scientific Reports, vol. 10, no. 1, Nov. 2020, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41598-020-76882-w.

APA

Inomata, T., Fujimoto, K., Okumura, Y., Zhu, J., Fujio, K., Shokirova, H., Miura, M., Okano, M., Funaki, T., Sung, J., Negishi, N., & Murakami, A. (2020). Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival. Scientific Reports, 10(1), 1–11. https://doi.org/10.1038/s41598-020-76882-w

Chicago

Inomata, Takenori, Keiichi Fujimoto, Yuichi Okumura, Jun Zhu, Kenta Fujio, Hurramhon Shokirova, Maria Miura, et al. 2020. “Novel Immunotherapeutic Effects of Topically Administered Ripasudil (K-115) on Corneal Allograft Survival.” Scientific Reports 10 (1): 1–11. doi:10.1038/s41598-020-76882-w.